These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 234592)

  • 21. [Beta-blocking compounds and production of ATP in leukocytes of hyperthyroid subjects].
    Jemelin M; Scazziga B; Frei J
    Schweiz Med Wochenschr; 1970 Mar; 100(12):543-4. PubMed ID: 4392046
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problems in the treatment of hyperthyroidism].
    Schweiz Rundsch Med Prax; 1976 Sep; 65(38):1185. PubMed ID: 11460
    [No Abstract]   [Full Text] [Related]  

  • 23. [New symptomatic therapeutics].
    Benoit G
    Lille Med; 1972 Dec; 17(11):1567-8. PubMed ID: 4150042
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical use of adrenergic beta blockaders].
    Desruelles J; Delbecque H; Waucampt JJ; Dekiester P
    Lille Med; 1974 Mar; 19(3):302-7. PubMed ID: 4155039
    [No Abstract]   [Full Text] [Related]  

  • 25. Atrial natriuretic peptide in hyperthyroidism: effect of beta-adrenergic blockade.
    Yoshinari M; Kuroda T; Ikenoue H; Okamura K; Sato K; Fujishima M
    Klin Wochenschr; 1990 Apr; 68(8):441. PubMed ID: 1971858
    [No Abstract]   [Full Text] [Related]  

  • 26. [The cardioselective beta blocker bisoprolol. Value in the therapy of florid hyperthyroidism].
    Jungmann E; Rosak C; Schifferdecker E; Schumm-Draeger PM; Schöffling K
    Fortschr Med; 1986 Sep; 104(35):661-4. PubMed ID: 2876939
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of beta-blocking agents in hyperthyroidism.
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis.
    Felt V
    Rev Czech Med; 1970; 16(3):140-4. PubMed ID: 4393594
    [No Abstract]   [Full Text] [Related]  

  • 29. [The medical treatment of hyperthyroidism (author's transl)].
    Joly J; Luton JP
    Chirurgie; 1978 Jun; 104(4):694-701. PubMed ID: 81736
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of adrenergic beta blockaders in thyrotoxicosis and hypothyroidism].
    Feldstein CA; Duhart JE; Henry EC; Degrossi OJ
    Prensa Med Argent; 1970 May; 57(9):454-8. PubMed ID: 4397115
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic use of agents acting on alpha and beta receptors].
    Soballa G
    Fortschr Med; 1974 Apr; 92(11):461-6. PubMed ID: 4150787
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-blockade--selection and use.
    Heikkilä J; Jounela A; Katila M; Luomanmäki K; Frick MH
    Ann Clin Res; 1979 Dec; 11(6):267-89. PubMed ID: 44825
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta-adrenergic blocking therapy in thyrotoxicosis].
    Erikssen J
    Tidsskr Nor Laegeforen; 1970 Jun; 90(11):1206-10. PubMed ID: 4393742
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of beta blockade on the peripheral manifestations of thyrotoxicosis.
    Grossman W; Robin NI; Johnson LW; Brooks H; Selenkow HA; Dexter L
    Ann Intern Med; 1971 Jun; 74(6):875-9. PubMed ID: 4397168
    [No Abstract]   [Full Text] [Related]  

  • 35. [Beta-adrenergic receptor blockaders].
    Zhdanova NS; Liakishev AA
    Ter Arkh; 1969 Mar; 41(3):10-21. PubMed ID: 4391123
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hyperthyroidism in type 1 diabetics].
    Schröder H
    Med Monatsschr Pharm; 2004 Jan; 27(1):21-2. PubMed ID: 14752929
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adrenergic beta blocking agents].
    Policlinico Prat; 1969 May; 76(18):584-8. PubMed ID: 4396175
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-adrenergic receptor blocking agents in therapy].
    Gutová M
    Cesk Pediatr; 1976 Nov; 31(11):641-6. PubMed ID: 13936
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of thyrotoxicosis. With special reference to the use of beta blockaders].
    Solem JH
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1975-9. PubMed ID: 6109381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.